Ellen
1.25 SEK -0.79%Be the first to follow this company
Ellen specializes in biotechnology. The company focuses on products for women's health. Ellen develops and sells sanitary protection for women based on probiotics (lactic acid bacteria). The products are sold under separate brands. The largest operations are held in the Nordic and European markets, where sales take place via licensed distributors. The company was established in 2000 and is headquartered in Stockholm.
Revenue
25.59M
EBIT %
-11.68 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ELN
Daily low / high price
1.25 / 1.26
SEK
Market cap
13.85M SEK
Turnover
188 SEK
Volume
150
Financial calendar
General meeting
2024-05-23
Interim report
2024-08-30
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Lövgren & Partners AB | 21.7 % | 21.7 % |
Sven Mattson | 15.9 % | 15.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Marknadsuppdatering: Ellen AB levererar ett positivt resultat för perioden januari till mars 2024
Ellen AB offentliggör Bokslutskommuniké 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools